Skip to main navigation menu Skip to main content Skip to site footer
FrancoAngeli Journals

Saggi

No. 126 (2023)

Buying innovation in healthcare: Sharing responsibilities and roles. The case of purchasing diagnostic services through Value-Based Procurement

DOI
https://doi.org/10.3280/mesa2023-126oa17287
Submitted
febbraio 16, 2024
Published
2024-04-24

Abstract

Buying innovation in healthcare: sharing responsibilities and roles. The case of purchasing diagnostic services through Value-Based Procurement (VBP). In public procurement of goods and services in healthcare, an innovative approach has recently emerged, called Value-Based Procurement, which represents a change from the traditional short-term cost savings model towards a more comprehensive approach, in which the performance of the healthcare system, patient outcomes, as well as the long-term efficiency and effectiveness of decisions are fundamental elements. In this article, this model is applied to the purchase of a diagnosis service for cancer, for which the use of the “mutational model” is gaining ground, characterized by the use of diagnostic tests to search not so much for the tumor site as for the type of genetic mutation. The purpose of the work is the construction of a purchasing model based on value, in a particularly complex and multi-level scenario, defining objectives to be pursued, key indicators to evaluate the effects of innovation, methods of measuring the value generated for the various players involved (health system; patients; suppliers).

References

  1. Amatucci F. et al. (2018). La funzione acquisti nel SSN alla luce dei processi di aggregazione della domanda: attori e strumenti. In: Cergas Bocconi (a cura di). Rapporto OASI. Milano: Egea.
  2. Baumhauer J.F., Bozic K.J. (2016). Value-based healthcare: Patient-reported outcomes in clinical decision making. Clinical Orthopaedics & Related Research, 474(6): 1375-1378.
  3. Campbell B., Campbell M., Dobson L., Higgins J., Dillon B., Marlow M. et al. (2018). Assessing the value of innovative medical devices and diagnostics: the importance of clear and relevant claims of benefit. Int J Technol Assess Health Care, 34(4): 419-24.
  4. Cappellaro G. et al. (2015). Gli impatti del PPP nel ridisegno dell’offerta ospedaliera: esiti, determinanti, prospettive. In: Cergas Bocconi (a cura di). Rapporto OASI 2015. Milano: Egea.
  5. Catalyst N. (2017). What is value-based healthcare?. NEJM Catalyst, 3(1).
  6. Cattel D., Eijkenaar F. (2019). Value-based provider payment initiatives combining global payments with explicit quality incentives: A systematic review. Medical Care Research and Review, 77(6): 511-537.
  7. Cattel D., Eijkenaar F., Schut F.T. (2018). Value-based provider payment: towards a theoretically preferred design. Health Economics, Policy and Law, 15(1): 94-112.
  8. Conrad D. A. (2015). The theory of value-based payment incentives and their application to health care. Health Services Research, 50(S2): 2057-2089.
  9. Conrad D.A., Grembowski D., Hernandez S.E., Lau B., Marcus-Smith M. (2014). Emerging lessons from regional and state innovation in value-based payment reform: Balancing collaboration and disruptive innovation. Milbank Quarterly, 92(3): 568-623.
  10. Cusumano N. et al. (2020). Evoluzioni e impatti della centralizzazione degli acquisti nel SSN: proposte per il miglioramento dei sistemi regionali. In: Cergas Bocconi (a cura di). Rapporto OASI. Milano: Egea.
  11. Dohmen P.J.C., Erik M. Van Raaij E.M. (2019). A new approach to preferred provider selection in health care. Health Policy, Mar, 123(3): 300-305.
  12. Eggleston K. (2005). Multitasking and mixed systems for provider payment. Journal of health economics, 24(1): 211-223.
  13. Eijkenaar F. (2013). Key issues in the design of pay for performance programs. The European Journal of Health Economics, 14(1): 117-131.
  14. Elf M. et al. (2017). The case of value-based healthcare for people living with complex long-term conditions. BMC Health Services Research, 17(1).
  15. Gerecke G., Clawson J., Verboven Y. (2015). Procurement: the unexpected driver of value-based health care. Boston: Boston Consulting Group.
  16. Gray M. (2017). Value based healthcare. BMJ. Institut du Québec (2017). Adopting Health Care Innovations in Quebec: Suggested Alternative Models.
  17. Krantz H., Strain B., Torzewski J. (2017). Medical device innovation and the value analysis process. Surgery, 162(3): 471-6.
  18. Kull S., Atanasov P., Jonas N. (2018). Value-based procurement of medical equipment in europe – did the 2014 eu directive influence tendering practices and evidence demand?. Value Health, 21: S267-S.
  19. Liu T.C., Bozic K.J., Teisberg E.O. (2017). Value-based healthcare: Person-centered measurement: Focusing on the three c’s. Clinical Orthopaedics & Related Research, 475(2): 315-317.
  20. Martelli N., Hansen P., van den Brink H., Boudard A., Cordonnier A.L., Devaux C. et al. (2016). Combining multi-criteria decision analysis and mini-health technology assessment: A funding decision-support tool for medical devices in a university hospital setting. J Biomed Inform, 59: 201-8.
  21. Martini N., Marchetti P. (a cura di) (2019). Il nuovo modello mutazionale in oncologia. Cosa cambia nella pratica clinica e assistenziale, nella ricerca e nelle procedure regolatorie. Roma: Il Pensiero Scientifico Editore.
  22. Messori A., Trippoli S. (2017). Value-based procurement of prostheses for total knee replacement. Orthop Rev., 9(4).
  23. Miller F.A., Lehoux P., Peacock S., Rac V.E., Neukomm J., Barg C. et al. (2019). How Procurement Judges the Value of Medical Technologies: A Review of Healthcare Tenders. Int J Technol Assess Health Care, 35(1): 50-5.
  24. Mosessian C. (2016). Value Based Purchasing: Decision-Making Processes Underlying Hospital Acquisitions of Orthopedic Devices [Sc.D.]. Ann Arbor: University of Southern California.
  25. Obremskey W.T., Dail T., Jahangir A.A. (2012). Value-based purchasing of medical devices. Clin Orthop Relat Res., 470(4): 1054-64.
  26. Pennestrì F., Lippi G., Banfi G. (2019). Pay less and spend more; he real value in healthcare procurement. Ann Transl Med., 7 (22).
  27. Prada G. (2016). Value-based procurement: Canada’s healthcare imperative. Healthcare management forum. Los Angeles, CA: SAGE Publications Sage.
  28. Pinto C., Normanno N., Jommi C., Altini M., Ravasio G. (2021). Profilazione genomica del NSCLC: confront tra metodiche standard e test NGS.
  29. Porter M., Olmested Teisberg E. (2006). Redefining Health Care. Boston: Harvard School Press.
  30. Putera I. (2017). Redefining health: Implication for value-based healthcare reform. Cureus, 9(3).
  31. Rahmani K., Karimi S., Rezayatmand R., Raeisi A.R. (2021). Value based procurement for medical devices: a scoping review. Med J Islam Repub Iran, 35: 134.
  32. Robinson J.C. (2008). Value-based purchasing for medical devices. Health Aff., 27(6): 1523-31.
  33. Squitieri L., Bozic K.J., Pusic A.L. (2017). The role of patient-reported outcome measures in value-based payment reform. Value in Health, 20(6): 834-836.
  34. Tarricone R., Torbica A., Ferre F., Drummond M. (2014). Generating appropriate clinical data for value assessment of medical devices: what role does regulation play?. Expert Rev Pharmacoecon Outcomes Res., 14(5): 707-18.
  35. Trippoli S. et al. (2018). Value-based procurement of medical devices: Application to devices for mechanical thrombectomy in ischemic stroke. Clin Neurol Neurosurg, 166: 61-5.
  36. Vecchi V., Cusumano N., Callea G., Amatucci F., Brusoni M., Zurlo F., Mauro C., Longo F. (2023). Acquisti sanitari: stato dell’arte e percorsi evolutivi verso logiche di valore. In: Cergas Bocconi (a cura di). Rapporto OASI 2023. Milano: Egea.
  37. Vecchi V., Casalini F. (2018). Is a sociale empowerment of PPP for infrastructure delivery possible?. Lesson from social impact bonds, Annals of Public and Cooperative Economics.
  38. Vecchi V., Cusumano N., Callea G. (2020). Verso un procurement sanitario strategico nel post Covid. Il caso delle scorte. Il Sole 24 Ore Sanità.
  39. Vecchi V., Cusumano N., Amatucci F., Brusoni M., Callea G., Longo F. (2020). Dal procurement operativo al procurement strategico: il punto di vista del mercato. Il Sole 24 Ore Sanità.
  40. Yin R.K. (2013). Case Study Research: Design and Methods, 5th edition. Thousand Oaks: Sage Publications.

Metrics

Metrics Loading ...